Salt Lake City, Utah - ShedRx, a trusted leader in personalized weight-loss solutions, is excited to announce the availability of name-brand weight-loss medications Wegovy®, Ozempic®, and Mounjaro® to help individuals take control of their health and achieve their weight-loss goals.

Wegovy® and Ozempic® are prescription medications that contain semaglutide, a GLP-1 receptor agonist, which works by helping regulate appetite, improve blood sugar control, and promote sustainable weight loss. Mounjaro® is a prescription medication that contains tirzepatide, which includes both a GLP-1 receptor agonist and another metabolic hormone called GIP. This has shown to be highly effective for weight loss and may even provide fewer side effects than semaglutide for some patients.

These FDA-approved treatments have gained significant recognition for their effectiveness in supporting individuals on their weight-loss journey, with Wegovy® specifically designed for weight management and Ozempic® and Mounjaro® originally developed for Type 2 diabetes management. 

ShedRx is proud to offer these well-known, high-quality medications as part of its comprehensive weight-loss and wellness services. With the support of a dedicated team of healthcare professionals, patients can receive personalized treatment plans tailored to their needs and lifestyles. 

Key benefits of Wegovy®, Ozempic®, and Mounjaro® include: 

Appetite Regulation: They help reduce hunger and promote portion control. 

Sustained Weight Loss: Clinical studies show that semaglutide can lead to significant weight loss when combined with a healthy diet and exercise. 

Blood Sugar Management: Ozempic® is designed to help regulate blood sugar levels for those with type 2 diabetes. 

"We are thrilled to offer Wegovy®, Ozempic®, and Mounjaro® to our patients," said Morley Baker, founder and CEO of ShedRx. "These medications are changing the way people approach weight loss and with our personalized coaching support and GLP-1 co-pilots, we can help individuals maximize their success in a safe and sustainable way." 

At ShedRx, patients are empowered with the knowledge and tools to make lasting lifestyle changes, supported by a team of medical professionals who understand the importance of individualized care. 

About ShedRx: 

ShedRx is a leading provider of weight loss and wellness services, offering a range of solutions tailored to meet the unique needs of each individual. With a focus on personalized care, ShedRx helps patients make meaningful, long-term health improvements by combining innovative treatments, expert guidance, and ongoing support. 

For more information on Wegovy®, Ozempic®, and Mounjaro®, or to schedule a consultation through ShedRx to meet with a healthcare provider, please visit shedrx.com.

Ozempic® and Wegovy® are trademarks of Novo Nordisk A/S. Mounjaro® is a registered trademark of Eli Lilly and Co., d/b/a Lilly. ShedRx has no ownership over brand-name, FDA-approved medications or products. 

To learn more about Novo Nordisk products, please visit https://www.novonordisk.com/our-products/our-medicines.html. 

To learn more about Lilly products, please visit https://www.lilly.com/our-medicines/current-medicines.

Media Contact

Name
ShedRx
Contact name
Jamie Neider
Contact phone
(801) 520-5785
Contact address
3401 N Thanksgiving Way
City
Lehi
State
UT
Zip
84043
Country
United States
Url
https://www.shedrx.com/